MedPath

TriNessa

TriNessa Tablets (norgestimate and ethinyl estradiol)

Approved
Approval ID

69e66f08-be0b-4120-9a30-333b34ad3507

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Sep 13, 2011

Manufacturers
FDA

Rebel Distributors Corp

DUNS: 118802834

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Norgestimate and Ethinyl Estradiol

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code21695-407
Application NumberNDA019697
Product Classification
M
Marketing Category
C73594
G
Generic Name
Norgestimate and Ethinyl Estradiol
Product Specifications
Effective DateDecember 22, 2009
FDA Product Classification

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

TriNessa - FDA Drug Approval Details